Brief: Mayne Pharma Receives Purported Notice To Terminate SID
04/06/2025 07:12
June 4 (Reuters) - Mayne Pharma Group Ltd MYX.AX: MAYNE PHARMA RECEIVES PURPORTED NOTICE TO TERMINATE SID-MYX.AX MAYNE PHARMA RECEIVES PURPORTED NOTICE TO TERMINATE SCHEME IMPLEMENTATION DEED FROM COSETTE INTENDS TO REJECT COSETTE TERMINATION NOTICE AS INVALID, REITERATES POSITION THAT NO MAYNE MATERIAL ADVERSE CHANGE TRIGGERED Further company coverage: MYX.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mayne Pharma
See all newsBrief: Mayne Pharma Group Says It Settles Us Patent Litigation Re Imvexxy With Teva USA
Deals of the day-Mergers and acquisitions
Brief: Mayne Pharma Says Supreme Court Dismisses Cosette Appeal
Deals of the day-Mergers and acquisitions
Australian court dismisses Cosette appeal to drop Mayne Pharma takeover (updated)